5 November 2024

Howe Street Reporter Title

Tag: asparaginase

  • ERYTECH Pharma (ERYP.Q) has a GRASPA® on ALL, shares up +70%

    ERYTECH Pharma (ERYP.Q) has a GRASPA® on ALL, shares up +70%

    A Need for Alternatives $54.898M Market Capitalization ERYTECH Pharma (ERYP.Q) announced today that the Company has sold its US manufacturing facility to Catalent, a leading contract development and manufacturing organization (CDMO) in advanced therapies. Under the terms of the agreement, Catalent has agreed to purchase ERYTECH’s US facility for a total consideration of $44.5 million. That’s…